Research programme: HIV vaccines - ChronTech

Drug Profile

Research programme: HIV vaccines - ChronTech

Latest Information Update: 15 Nov 2014

Price : $50

At a glance

  • Originator Tripep
  • Developer ChronTech Pharma
  • Class AIDS vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.


Highest Development Phases

  • Preclinical HIV infections

Most Recent Events

  • 15 Nov 2014 Preclinical development is ongoing in Sweden
  • 21 Apr 2011 Preclinical development is ongoing in Sweden
  • 11 Sep 2009 The programme is still in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top